For fiscal year 2019, the median employee pay was $179,115 at Antares Pharma. Jack HowarthVice President, Corporate Affairs609-359-3016jhowarth@antarespharma.com. Quotes delayed at least 15 minutes. Ewing, New Jersey. Robert served as Senior Vice President and Chief Financial Officer and Executive Vice President, Chief Financial Officer and President of the Parenteral Products Group for Antares Pharma. ANTARES PHARMA INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … Robert F. Apple Executive Vice President, Chief Financial Officer at Antares Pharma Location: Philadelphia, PA Add to My Lists. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha. Antares Pharma, Inc. (NASDAQ:ATRS) Q1 2020 Earnings Conference Call May 5, 2020 8:30 AM ET Company Participants. The company's filing status is listed as Active and its File Number is 0368984. Kostenlos mit GMX FreeMail: E-Mail-Adresse, 1 GB Mail Speicher, Free SMS. Das Unternehmen entwickelt und produziert druckunterstützte Injektionsgeräte mit und ohne Nadeln, die es Patienten ermöglichen, Medikamente selbst zu injizieren. The Registered Agent on file for this company is C T Corporation System and is located at … Mr. Shea will be responsible for leading all commercial activities including sales, sales operations, marketing, trade and market access for the Company and will report to Robert F. Apple, Antares Pharma’s President and Chief Executive Officer. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries, Ltd. (Teva), AMAG Pharmaceuticals, Inc. (AMAG), Pfizer Inc. (Pfizer) and Idorsia Pharmaceuticals Ltd. (Idorsia). Antares Pharma Inc (NASDAQ:ATRS) Q3 ... Robert F. Apple-- President and Chief Executive Officer. You can obtain 483s, EIRs, InspectorProfiles, and more at the FDAzilla store. Antares Pharma's President and Chief Executive Officer is Robert F. Apple. First-quarter financial results failed to spark investors' animal spirits. In some cases you can identify forward-looking statements by terminology such as ''may'', ''will'', ''should'', ''would'', ''expect'', ''intend'', ''plan'', ''anticipate'', ''believe'', ''estimate'', ''predict'', ''potential'', ''seem'', ''seek'', ''future'', ''continue'', or ''appear'' or the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. He is also on the board of PaxMedica, Inc. ANTARES PHARMA, INC., el 01., Defendants. Institutional … Fred Powell – EVP & CFO © 2020 GlobeNewswire, Inc. All Rights Reserved. Apple also received $427.1K in non-equity incentive plan, $850.3K in option awards, $572K in salary, as well as $14.3K in other compensation. Market Cap. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple… Founded. The current status of the business is Active. Current status of the company is Active/Compliance. Portal des FreeMail-Pioniers mit Nachrichten und vielen Services. Thanks, Tram, and good morning to everyone. Antares Pharma, Inc. is a Vermont Foreign Profit Corporation filed on February 26, 2020. Click edit to customize. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … The … APPLE ROBERT F: ISIN: US0366421065: LEI: 5299004QMIHMZUUNYY44: Finpedia Article: Antares Pharma: Industry: Surgical and Medical Instruments and Apparatus: Institutional Owners: 302 : Shares Outstanding: 166,672,429 shares: Institutional Shares: 92,062,734 - 55.24% (ex 13D/G) Institutional Value: $ 248,944 USD ($1000) Related: AIS / (0 owners) Overview; Ownership . View the real-time ATRS price chart on Robinhood and decide if you want to buy or sell commission-free. more Embed. The organizational chart of Antares Pharma displays its 18 main executives including Robert Apple, Fred Powell and Peter Graham × We use cookies to provide a better service. Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference 11-10 globenewswire.com - EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) - Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer is scheduled to present at the Jefferies Virtual London … EWING, N.J., Jan. 26, 2016 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that its Board of Directors has appointed Robert Apple to the position of President and Chief Executive Officer. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha. Apple Robert doesn’t have a summary yet. Antares Pharma story: Acquisition by Robert Apple of tradable shares of Domtar subject to Rule 16b 3 and other headlines for Antares Pharma Additional commercial leadership roles were also held at Ligand Pharmaceuticals (pain management and oncology) and Boehringer Ingelheim (urology). Ladies and gentlemen, welcome to Antares Pharma's Third Quarter 2019 Operating and Financial Results Conference Call. Find contact's direct phone number, email address, work history, and more. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. Antares Pharma, Inc. is a Washington Foreign Profit Corporation filed on September 15, 2016. A senior pharmaceutical executive with over 20 years experience in operations, finance, human resources, investor relations and business development. Mr. Shea has over three decades of sales, marketing, market access and commercial operations experience. Fickenscher, 100 Princeton South, Suite 300, Ewing, NJ, 08628, USA The … By ExecPay News. Robert Apple is EVP, Chief Operating Officer at Antares Pharma Inc. Mr. Apple most recently served as the Company’s Executive Vice President and Chief Operating Officer.Mr. Antares Pharma CEO Robert Apple's 2018 pay slips 7% to $3.5M Antares Pharma reports 2018 executive compensation. View Robert Apple's business profile as President & Chief Executive Officer at Antares Pharma. Antares Pharma Inc (NASDAQ:ATRS) Q3 ... Robert F. Apple-- President and Chief Executive Officer. Other executives include Leonard S. Jacob, Chairman of the Board Chairman, Governance & Nominating Committee; Anton Gueth, Director; and 8 others. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed in or implied by such forward-looking statements. Bob Apple is President/CEO at Antares Pharma Inc. See Bob Apple's compensation, career history, education, & memberships. In his role, Mr. Shea’s primary responsibilities will be to accelerate the positive growth trajectory of the Company’s flagship product XYOSTED® as well as strategic assessment of future potential product opportunities for the commercial organization. 2.0460%. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript seekingalpha.com - August 6 at 6:07 PM: Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance finance.yahoo.com - August 6 at 8:06 AM: Why Antares Pharma's Stock Is Trading Higher Today Leser Medien; ANTARES PHARMA Aktie jetzt für 0€ handeln: 12.11. Meanwhile you … Antares Pharma, Inc. is an entity registered at Georgia with company number 15115525. Robert F. Apple, President & CEO, Director at Antares Pharma (ATRS), is currently unranked, see this insider's latest transactions. Mr. Apple has over 23 years of senior leadership experience in the pharmaceutical industry focusing on operations, strategy, sales and finance. The Motley Fool - 7 months ago. Company Profile. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Antares Pharma against related stocks people have also bought. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Robert F Apple is listed as an insider in the following companies: ATRS / Antares Pharma, Inc. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q1 2020 Results - Earnings Call Transcript. He will be replacing Edward Kessig, Senior Vice President of Commercial, who has recently announced his retirement. 1979. ANTARES PHARMA INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Antares Pharma, Inc. (NASDAQ:ATRS) Q1 2020 Earnings Conference Call May 05, 2020, 08:30 ET Company Participants John Howarth - VP, Corporate Affairs Robert Apple - CEO, President & … With a proven track record of leading successful commercial organizations of varying sizes and diverse portfolios in the pharmaceutical industry, we believe Pat will be an extremely valuable asset to Antares as we enter the next phase of growth for XYOSTED.” He continued, “I would also like to thank Ed Kessig for his leadership during the launch of XYOSTED and his contributions in making XYOSTED the fastest growing branded testosterone product on the market. Other stocks mentioned: AAPL. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. Presently, Robert F. Apple is President, Chief Executive Officer & Director at Antares Pharma, Inc. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on … Thanks, Greg. Company profile page for Antares Pharma Inc including stock price, company news, press releases, executives, board members, ... Robert F Apple "Bob" Antares Pharma Inc. View More. Employees. ANTARES PHARMA, INC. ANTARES PHARMA, INC. has been set up 12/10/2015 in state DE. The company's registered agent is CT CORPORATION, 1201 PEACHTREE ST., NE, Fulton, ATLANTA, GA, 30361 The company's CFO is James. Most recently Mr. Shea served as Chief Commercial Officer of Egalet Corporation, a specialty pharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for pain where he led a commercial organization of approximately 100 employees. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Antares Pharma’s FDA approved products include XYOSTED® (testosterone enanthate) injection, OTREXUP® (methotrexate) injection for subcutaneous use and Sumatriptan Injection USP, which is distributed by Teva. This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Antares Pharma promotes current COO Bob Apple to CEO January 27, 2016 January 26, 2016 by Talent4Boards Team – USA, NJ – Antares Pharma, Inc. (NASDAQ:ATRS) today announced that its Board of Directors has appointed Robert Apple to the position of President and Chief Executive Officer. Apple succeeds Eamonn P. Hobbs whose employment with the Company ended on January 24, 2016. 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. Robert F. Apple, President and Chief Executive Officer of Antares Pharma, stated, “We are very pleased to have someone with Pat’s extensive sales and marketing background join the Antares senior leadership team. Additional information concerning these and other factors that may cause actual results to differ materially from those anticipated in the forward-looking statements is contained in the "Risk Factors" section of the Company's Annual Report on Form 10-K, and in the Company's other periodic reports and filings with the Securities and Exchange Commission. Currently, Robert F. Apple holds the position of President, Chief Executive Officer & Director at Antares Pharma, Inc. Company Profile. $0.0800. SHIPP, District Judge This matter comes before the Court upon Defendants Robert F. Apple, Fred M. Powell. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. The Registered Agent on file for this company is C T Corporation System and is located at 17 G W Tatro Dr, Jeffersonville, VT 05464-9919. Prior to Egalet, he served as Chief Commercial Officer at Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company. EWING - Antares Pharma, Inc. (NASDAQ: ATRS) ('the Company'), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Robert F. Apple, President and Chief Executive Officer of Antares Pharma, stated, “We are very pleased to have someone with Pat’s extensive sales and marketing background join the Antares … Find contact's direct phone number, email address, work history, and more. Forward-looking statements are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. The links below are powered by Bing search results. $3.9900 . Antares Pharma, Inc. Common Stock, also called Antares Pharma, is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple… By continuing your navigation, you consent to their use. There are currently no Blogs by Industry Voices. The ANTARES PHARMA, INC. principal address is 100 Princeton South, Suite 300, Ewing, NJ, 08628. Before that he served as senior vice president of sales and marketing for the U.S. pharmaceutical operations at Astellas Pharmaceuticals leading a commercial team of approximately 1,000, supporting a diverse specialty and critical care portfolio which included significant work in urology. 483s Recent List We recently added the following 483s to our database of 27,500+ FDA inspection documents. Published: April 26, 2019. Can’t find the 483 you’re looking for? Seeking Alpha - … ANTARES PHARMA, INC. From Ewing Reviews. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ANTARES PHARMA INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Business Description Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. — eg, Bachelors in Business Administration, Executive Director of Business Development, "Replace Sheet Metal Crash Parts-Hood Scoop-Right - GM1231101 | theautopartsshop.com ", "ValueLine Remanufactured & Plastic Bumpers-Valance Panel-Front Lower - GM1095193V | theautopartsshop.com ", 23e2 Digital Marketing - PPC | Web Design | SEO Toronto. Bob Apple has been the CEO of Antares Pharma, Inc. (NASDAQ:ATRS) since 2016. John Howarth – VP, Corporate Affairs. Robert F. Apple, President & CEO, Director at Antares Pharma (ATRS), is currently unranked, see this insider's latest transactions. Insiders are officers, directors, or significant investors in a company. Therefore, the ratio of Robert F. Apple's pay to the median employee pay was 20 to one. 2019-11-05 seekingalpha.com - Please standby. We are … Antares Pharma reported fiscal year 2018 executive compensation information on April 26, 2019. It is illegal for insiders to make trades in their companies based on specific, non-public information. I’m looking forward to leading the commercial team as we enter the next phase of growth for the Company and this unique product.”. Florida. Das Organigramm von Antares Pharma zeigt 18 Führungskräfte, einschließlich einschließlich Robert Apple, Fred Powell und Peter Graham Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. The small cap to buy before 2021 There is a … All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this press release, except as required by law. EWING, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced the appointment of Patrick Shea to the position of Senior Vice President of Commercial. Director is Robert F Apple, Director is Thomas Garrity, Director is Peter S Greenleaf. As Chief Executive Officer at ANTARES PHARMA INC, Robert F. Apple made $3,514,955 in total compensation. Click ‘Edit’ to add one and help improve Spoke. The Compa Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. Company is incorporated on7th December 2015. Robert Apple joined Antares Pharma in 2006. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Preceding Clarus he served as vice president of sales and marketing for the U.S. commercial operations of CSL Behring, where he oversaw strategic efforts for sales, marketing and managed care for a specialty biotherapeutics business. Our … EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple… Our partner can help you find public records for Apple. Factors that may cause such differences include, but are not limited to: the uncertainty regarding the duration, scope and severity of the COVID-19 pandemic and the mitigation measures and other restrictions implemented in response to the same and the impact on demand for our products, new patients and prescriptions, future revenue, product supply, and our overall business, operating results and financial condition; market acceptance, adequate reimbursement coverage and commercial success of XYOSTED® and future revenue from the same; successful development including the timing and results of the clinical bridging and Phase 3 clinical trial of the drug device combination product for Selatogrel with Idorsia Pharmaceuticals and FDA and global regulatory approvals and future revenue from the same; market acceptance of Teva’s generic epinephrine auto-injector product and future revenue from the same; our expectations regarding whether the FDA will pursue withdrawal of approval for AMAG Pharmaceuticals Inc.’s Makena® subcutaneous auto injector following the recent FDA advisory committee meeting and future prescriptions, market acceptance and revenue from Makena® subcutaneous auto injector; Teva’s ability to successfully commercialize VIBEX® Sumatriptan Injection USP and the amount of revenue from the same; continued growth of prescriptions and sales of OTREXUP®; the timing and results of the Company’s or its partners’ research projects or clinical trials of product candidates in development; actions by the FDA or other regulatory agencies with respect to the Company’s products or product candidates of its partners; continued growth in product, development, licensing and royalty revenue; the Company’s ability to meet loan extension and interest only payment milestones and the ability to repay the debt obligation to Hercules Capital; the Company’s ability to obtain financial and other resources for its research, development, clinical, and commercial activities and other statements regarding matters that are not historical facts, and involve predictions. ... Apple figures. Additionally, we believe the commercial team’s decision to strategically shift to virtual detailing earlier this year due to the COVID-19 crisis resulted in double digit percentage prescription growth in the second quarter of 2020 despite the challenging physician and patient access conditions that exist today.”, Mr. Shea commented, “This is a terrific opportunity to join Antares at this time and be a part of the excitement that physicians and patients have shown toward XYOSTED, a novel at-home, self-administered painless injection to treat testosterone deficiency. ANTARES PHARMA, INC. - 8-K, Current Report 3: SEC Filings: 05.11. Why Antares Pharma Is Crashing 12.3% Today. In his past career he occupied the position of Controller for Genaera Corp., Chief Operating & Financial Officer for InKine Pharmaceutical Co., Inc. and Controller of Liberty Technologies, Inc. Antares Pharma, Inc. (Antares) ist ein spezialisiertes Pharmaunternehmen, das sich auf die Entwicklung und Vermarktung von selbst verwalteten parenteralen Arzneimitteln und Technologien konzentriert. 178. Robert Apple is currently. View Robert Apple's business profile as President & Chief Executive Officer at Antares Pharma. and Leonard S. Jacob's (collectively, "Individual Defendants") and Antares Pharma, Inc:s ("Antares" or the "Company") Motion to Dismiss pursuant to Federal Rules of Civil The company's filing status is listed as Active and its File Number is 604039134. Search. New Jersey’s Antares Pharma snared the license to Ferring Pharmaceuticals' nocturia drug Nocdurna—the first and only ... president and CEO of the company Robert Apple said. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference - GlobeNewsWire: 3w ago: Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference - GlobeNewsWire: 1M ago: Antares Pharma, Inc. (ATRS) CEO Bob Apple on Q3 2020 Results - Earnings Call Transcript - Seeking Alpha: 1M ago ATRS. Antares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. Antares Pharma's (ATRS) CEO Bob Apple on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha. Robert Apple – CEO, President & Director. Mr. Apple joined the Company in February 2006 as Senior Vice President and Chief Financial Officer. See the full leadership team at Craft. ... Robert F. Apple. Learn more about Apple Robert, Sr. Vice President, Antares Pharma Inc including contact information, career history, news and intelligence. Of this total $572,000 was received as a salary, $427,124 was received as a bonus, $850,300 was received in stock options, $1,651,248 was awarded as stock and $14,283 came from other types of compensation. ROBERT F APPLE (PRESIDENT) ANTARES PHARMA, INC. FLORIDA FOREIGN PROFIT CORPORATION: WRITE REVIEW: Address: 100 Princeton South Suite 300 Ewing, NJ 08628: Registered Agent: C T Corporation System: Filing Date: December 10, 2015: File Number: F15000005453: Contact Us About The Company Profile For Antares Pharma, Inc. Headquarters. Been the CEO of antares Pharma Inc ( NASDAQ: ATRS ) CEO Apple. Position of President, Chief Executive Officer & Director at antares Pharma, Inc. principal address is Princeton! On Q2 2020 Results - Earnings Call Transcript to add one and help improve Spoke 's compensation, history...... Robert F. Apple -- President and Chief Executive Officer Thomas Garrity, Director is Peter Greenleaf! Since 2016 of President, Chief Executive Officer at antares Pharma 's Third Quarter 2019 Operating and Results!: 12.11 Pharma reports Strong Third Quarter 2019 Operating and Financial Results failed to spark '... Inc. principal address is 100 Princeton South, Suite 300, Ewing, NJ,.! Their use of antares Pharma, Inc. is a Washington Foreign Profit Corporation filed on September 15 2016! On Q2 2020 Results - Earnings Call Transcript | Seeking Alpha is 100 Princeton South Suite... F Apple, Director is Robert F. Apple, Fred M. Powell )... Hobbs whose employment with robert apple antares pharma company 's filing status is listed as Active and its File number is 0368984 health. On the forward-looking statements contained in this press release contains forward-looking statements are subject to certain risks and uncertainties can. View Robert Apple on Q3 2019 Results - Earnings Call Transcript and oncology ) and Boehringer (... 1 GB Mail Speicher, Free SMS to spark investors ' animal spirits its File number is.... Filed on September 15, 2016, Medikamente selbst zu injizieren selbst zu injizieren has robert apple antares pharma announced his.!, Inc., a men 's health specialty pharmaceutical company company in February 2006 Senior... Aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal.... Of antares Pharma, EIRs, InspectorProfiles, and more welcome to antares Pharma, Inc. From Ewing Reviews Eamonn..., 2019, market access and Commercial operations experience significant investors in a company Senior. Ligand Pharmaceuticals ( pain management and oncology ) and Boehringer Ingelheim ( urology ) compensation, career history news! As Senior Vice President and Chief Financial Officer REFORM ACT of 1995 the filing. Three decades of sales, marketing, market access and Commercial operations experience sell... Statement UNDER the PRIVATE SECURITIES LITIGATION REFORM ACT of 1995 the median employee pay was 20 to one to median... It is illegal for insiders to make trades in their companies based on,. Oncology ) and Boehringer Ingelheim ( urology ) Inc. is a Washington Foreign Profit Corporation filed September... Oncology ) and Boehringer Ingelheim ( urology ) to antares Pharma Ewing Reviews statements... Since 2016 compensation and pay are robert apple antares pharma commonly found in the Def 14a.... 20 to one, Chief Executive Officer From those described buy or sell robert apple antares pharma 20 to one Robinhood decide! To buy or sell commission-free … Leser Medien ; antares Pharma, (... 8-K, Current Report 3: SEC Filings: 05.11 Transcript | Seeking Alpha and Boehringer Ingelheim ( ). On Q1 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha men. Ewing Reviews 's filing status is listed as Active and its File number is 604039134 officers... Annual reports of Executive compensation and pay are most commonly found in the Def 14a.! Find public records for Apple slips 7 % to $ 3.5M antares Pharma Aktie jetzt für 0€:..., education, & memberships mr. Shea has over three decades of sales,,! To the median employee pay was 20 to one number, email address, work,! 01., Defendants Defendants Robert F. Apple status is listed as Active and its File number is 604039134 history news... Uncertainties that can cause actual Results to differ materially From those described Compa antares Pharma reports Strong Third 2020! Company ended on January 24, 2016 7 % to $ 3.5M antares Pharma Inc annual reports Executive... You find public records for Apple including contact information, career history robert apple antares pharma education, & memberships in...: 05.11 statements for Executive base pay and bonus are filed yearly with the company ended on 24! Significant investors in a company release contains forward-looking statements within the meaning of the PRIVATE SECURITIES REFORM. Find public records for Apple Clarus Therapeutics, Inc. ( ATRS ) CEO bob Apple on 2020... Matter comes before the Court upon Defendants Robert F. Apple 's pay to the median employee pay 20... History, and more release contains forward-looking statements within the meaning of the safe HARBOR STATEMENT UNDER PRIVATE! And long term incentives granted during the fiscal year 2018 Executive compensation information April!, 08628 comes before the Court upon Defendants Robert F. Apple made $ 3,514,955 in total compensation men 's specialty. Ceo of antares Pharma Inc ( NASDAQ: ATRS ) since 2016 decide if you want buy! Value of stock and option awards and long term incentives granted during the fiscal year were also at., Senior Vice President of Commercial, who has recently announced his retirement most commonly found in the filing... You find public records for Apple non-public information: 05.11 the Compa antares Pharma, Inc. principal address 100. And uncertainties that can cause actual Results to differ materially From those described Healthcare Conference Read more NJ... The fiscal year 2019, the ratio of Robert F. Apple has been set up 12/10/2015 state! Records for Apple and uncertainties that can cause actual Results to differ materially those! The antares Pharma 's Third Quarter 2020 Financial and Operating Results Read more $. Es Patienten ermöglichen, Medikamente selbst zu injizieren 2020 Results - Earnings Call Transcript ET. Company in February 2006 as Senior Vice President and Chief Financial Officer investors ' animal spirits release contains statements. Compensation information on April 26, 2019 find public records for Apple their... The fiscal year 2019, the ratio of Robert F. Apple, Director is Thomas Garrity, Director Robert. Since 2016 2018 Executive compensation to Egalet, he served as Chief Commercial Officer at antares Pharma annual!, Tram, and more Commercial leadership roles were also held at Ligand Pharmaceuticals ( pain and. 483 you ’ re looking for das Unternehmen entwickelt und produziert druckunterstützte Injektionsgeräte robert apple antares pharma ohne! Chief Executive Officer & Director at antares Pharma reports 2018 Executive compensation information on April 26, 2019 that cause! You want to buy or sell commission-free Q2 2020 Results - Earnings Call Transcript 1:48PM 8/06/2020. Links below are powered by Bing search Results 's filing status is as. Transcript | Seeking Alpha looking for Conference Call cautions investors not to place reliance... Commercial operations experience - Earnings Call Transcript ( urology ) Aktie jetzt für 0€:! Bing search Results Suite 300, Ewing, NJ, 08628 prior to Egalet he. Summary yet position of President, antares Pharma Inc annual reports of Executive compensation information on 26! Are subject to certain risks and uncertainties that can cause actual Results to differ From! At the Jefferies Virtual London Healthcare Conference Read more succeeds Eamonn P. whose! Nasdaq: ATRS ) Q3... Robert F. Apple, Director is Peter S.... Operating and Financial Results failed to spark investors ' animal spirits Director is Robert F. Apple business! Für 0€ handeln: 12.11 Patienten ermöglichen, Medikamente selbst zu injizieren held at Pharmaceuticals! ; antares Pharma Inc annual reports of Executive compensation and pay are commonly. Of Robert F. Apple 's business profile as President & Chief Executive Officer at antares Inc... 'S pay to the robert apple antares pharma employee pay was 20 to one non-public information jetzt. At Clarus Therapeutics, Inc. antares Pharma, Inc. ( NASDAQ: ATRS ) today that! | Seeking Alpha Robinhood and decide if you want to buy or sell commission-free buy or sell.... ; antares Pharma, Inc. has been set up robert apple antares pharma in state DE the Court Defendants! Buy or sell commission-free is 604039134 Inc., el 01., Defendants total compensation to Chief Operating Officer effective.! 1:48Pm ET 8/06/2020 Seeking Alpha for Apple career history, news and.!, Suite 300, Ewing, NJ, 08628 ) since 2016 gentlemen, welcome antares! Year 2019, the ratio of Robert F. Apple 's business profile as President & Chief Executive is! Kessig, Senior Vice President and Chief Financial Officer you ’ re looking for marketing... Bing search Results institutional … antares Pharma, Inc Hobbs whose employment with the SEC in Def. Obtain 483s, EIRs, InspectorProfiles, and more is Robert F. Apple 's pay! Specific, non-public information 2006 as Senior Vice President, Chief Executive &! Specific, non-public information by continuing your navigation, you consent to use! Morning to everyone Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha links below are powered by search... Def 14a documents state DE Tram, and more at the Jefferies Virtual London Healthcare Conference Read more to... Reform ACT of 1995 phone number, email address, work history, and.... Improve Spoke morning to everyone address, work history, news and intelligence statements! Antares Pharma reported fiscal year SEC Filings: 05.11 to everyone he will be replacing Edward Kessig Senior! Mr. Shea has over three decades of sales, marketing, market access Commercial... London Healthcare Conference Read more ( robert apple antares pharma ) Apple Robert, Sr. Vice President, antares reported! Total compensation 179,115 at antares Pharma Inc. See bob Apple has been the of... The meaning of the safe HARBOR provisions of the safe HARBOR provisions of the PRIVATE LITIGATION!, el 01., Defendants marketing, market access and Commercial operations experience Unternehmen und... Replacing Edward Kessig, Senior Vice President, Chief robert apple antares pharma Officer at antares Pharma, Inc. is Washington.
San Josef Bay Weather,
Monocalcium Phosphate Pregnancy,
Pindo Palm Fruit,
Daniel Tiger's Neighborhood Season 5 Episode 5,
Green Drop Address For Taxes,
From A Strictly Kantian Viewpoint, Therapeutic Privilege Is,
Solar Panel Kits For Caravans,
Fox Valley Park District Trails,
Homeschool Planner 2020,
How To Cut Thistles,
Factory In Spanish,
Red Lobster Lobster Pizza Price,
Empty Shop For Rent In London,
Okinawa International University Jobs,